🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study evaluates the impact of ofatumumab in Relapsing Remitting Multip...
Status
Completed
Location
MD First Research
Start Date
2022-01-25
Trial ID
NCT05084638
Treatments Being Tested
The primary objective of the study is to evaluate the safety of idelalisib ...
Status
Completed
Location
Clearview Cancer Institute
Start Date
2010-03-25
Trial ID
NCT01088048
The purpose of this study was to evaluate the efficacy and safety of ofatum...
Status
Completed
Location
Novartis Investigative Site
Start Date
2022-07-22
Trial ID
NCT05199571
Treatments Being Tested
FDA-approved multiple sclerosis (MS) disease-modifying therapies (DMTs) tar...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Start Date
2018-05-02
Trial ID
NCT03500328
Treatments Being Tested
We aim to assess the effect of Ofatumumab on microglial activation using \[...
Status
Completed
Location
Brigham MS Center, 60 Fenwood Road
Start Date
2020-09-21
Trial ID
NCT04510220
Treatments Being Tested
The primary purpose of this study is to demonstrate pharmacokinetic bioequi...
Status
Completed
Location
Novartis Investigative Site
Start Date
2018-09-11
Trial ID
NCT03560739
Treatments Being Tested
The study provided efficacy, safety, and pharmacokinetics (PK) data for pat...
Status
Completed
Location
Novartis Investigative Site
Start Date
2018-03-15
Trial ID
NCT03249714
Treatments Being Tested
This study will compare ofatumumab vs. European approved platform first lin...
Status
Completed
Location
Novartis Investigative Site
Start Date
2021-07-23
Trial ID
NCT04788615
Treatments Being Tested
This is an uncontrolled, prospective, observational cohort study to assess ...
Status
Unknown
Location
Tianjin Medical University General Hospital
Start Date
2022-10-15
Trial ID
NCT05414487
Treatments Being Tested
Autoimmune encephalitis is an autoimmune disease of the central nervous sys...
Status
Recruiting
Location
The First Affiliated Hospital of Zhengzhou University
Start Date
2024-11-08
Trial ID
NCT06867991